Clinical Trials Browser

Phase 1/2 × Interventional × Erdheim-Chester Disease × Clear all

NCT04198818 2024-07-19

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Phase 1/2 Terminated

37 enrolled 30 charts

DermatologicMyeloidThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Erdheim-Chester Disease